BioSpace News Archive

Drug Development

Cerevance Announces First-in-Human Dosing of CVN424 for the Treatment of Parkinson’s Disease

Cerevance today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson’s disease.

September 25, 2018
·
2 min read
FDA

Exceed Microneedling device first to receive FDA clearance for the treatment of wrinkles

MT.DERM GmbH, Berlin, Germany, is excited to announce its expansion into the US market of its medical microneedling device, Exceed under the brand amiea med, exclusively available to healthcare professionals.

September 25, 2018
·
3 min read
Pharm Country

NeoTract Announces Results from Five Real-World Studies Reaffirming Efficacy and Safety of UroLift® System Treatment for Enlarged Prostate

Data in Diverse Patient Populations from Three Continents Presented at World Congress of Endourology 2018 Annual Conference

September 25, 2018
·
6 min read
Business

agilon health Achieves 20 Percent Boost In Closing Care Gaps By Using Physician And Member Incentives For Preventive Care

Company releases its Annual Quality Outcomes Report

September 25, 2018
·
3 min read
Drug Development

Intec Pharma to Present Multiple Posters at International Congress of Parkinson’s and Movement Disorder Society

Intec Pharma Ltd. today announces that three posters in support of the Company’s Phase 3 clinical development program for the Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD), will be presented at the upcoming International Congress of Parkinson’s and Movement Disorder Society (MDS 2018) being held from October 5-9, 2018 in Hong Kong.

September 25, 2018
·
5 min read
Genetown

Leap Therapeutics to Present at Two October 2018 Conferences

Leap Therapeutics, Inc. today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the following investor conferences

September 25, 2018
·
2 min read
Pharm Country

Orphan Star Therapeutics Announces Initial Financing and Corporate Update

Orphan Star Therapeutics, LLC today announced it has successfully secured a commitment of $20 million from a commercial pharmaceutical partner.

September 25, 2018
·
2 min read
Business

New American Cancer Society Cookbook Offers More Than 130 Recipes to Help Patients Cope with Nutrition Challenges While Undergoing Treatment

The American Cancer Society will release the second edition of What to Eat During Cancer Treatment on Oct. 1.

September 25, 2018
·
4 min read
Business

Toronto’s Waterfront is new destination for MaRS innovation hub

MaRS Discovery District, together with its partner University of Toronto, today announced that it is in the final stages of securing a lease with Menkes Developments Ltd. (“Menkes”) for a new 24,000-square-foot hub at Toronto’s Waterfront Innovation Centre.

September 25, 2018
·
2 min read
Biotech Bay

Ceribell Announces Completion Of $35 Million Series B Financing

Proceeds will be used to expand commercialization of its innovative Rapid Response EEG System to improve the diagnosis and treatment of patients at risk for seizures

September 25, 2018
·
5 min read